LoginRegister
    Glenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancerGlenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancer
    Granules India gets 2 USFDA observations for Chantilly facilityGranules India gets 2 USFDA observations for Chantilly facility
    Biocon wins European nod for Malaysia insulin facilityBiocon wins European nod for Malaysia insulin facility
    AstraZeneca diabetes drug Farxiga meets goal in heart failure trialAstraZeneca diabetes drug Farxiga meets goal in heart failure trial
    Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per dayNabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day
    Impact of Digital Health on Healthcare professionals: Key points from Phillips Future Health index 2019 ReportImpact of Digital Health on Healthcare professionals: Key points from Phillips Future Health index...
    Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic anginaZydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina
    Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma groupLupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group
    Pfizer infuses Rs 3597 crore to expand gene therapy plant in SanfordPfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford
    AstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKDAstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKD
    GSK: US pharma president Jack Bailey to step down in DecemberGSK: US pharma president Jack Bailey to step down in December
    Simple, uncluttered and transparent, Fortis CEO plans makeover: ReportSimple, uncluttered and transparent, Fortis CEO plans makeover: Report
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X